| 摘要: |
| 目的 探索透解祛瘟颗粒治疗新冠肺炎的活性成分及作用机制,为透解祛瘟颗粒在新冠肺炎防治中的应用提供科学依据。方法 通过查阅参考文献和TCMSP数据库检索筛选透解祛瘟颗粒的化学成分,采用TCMSP和CTD数据库检索透解祛瘟颗粒化学成分的靶蛋白或靶标基因,使用String 数据库进行蛋白-蛋白相互作用(PPI)分析得到核心靶点和核心化合物,通过Cytoscape软件构建可视化药材-活性成分-核心靶点网络,并进行拓扑分析和对核心靶点进行京都基因与基因组百科全书(KEGG)通路分析,再将核心化合物与血管紧张素转化酶 2(ACE2)、3CL水解酶(MPro)和木瓜样蛋白酶(PLP)进行分子对接,探讨其在抑制新冠病毒(SARS-CoV-2)感染和复制方面的活性;预测透解祛瘟颗粒防治新冠肺炎的作用机制。结果 网络拓扑分析筛选得到132个核心靶点和109个核心化合物,关键靶点涉及环氧化酶(PTGS2)、胱天蛋白酶3(CASP3)、白细胞介素6(IL-6)、肿瘤坏死因子(TNF)、TP53、AKT1、MAPK3、血管内皮生长因子A (VEGFA)、MAPK1、信号传导与转录激活因子3(STAT3)、JUN、甘油醛-3-磷酸脱氢酶(GAPDH)、INS、ALB和AR等。通路富集得到甲型流感、小细胞肺癌、肿瘤坏死因子、Toll样受体、PI3K-Akt和HIF-1等关键信号通路。分子对接结果表明,透解祛瘟颗粒中化学成分中与血管紧张素转化酶 2、3CL水解酶和木瓜样蛋白酶对接结果结合能超过平均值的化合物分别为58、64和56个。结论 透解祛瘟颗粒中的活性成分能通过作用于血管紧张素转化酶 2、3CL水解酶和木瓜样蛋白酶发挥抑制病毒感染宿主细胞及自我复制的进程,也能通过多靶点多通路抑制细胞因子风暴,减少肺纤维化的形成,改善低氧血症,有效的防治新冠肺炎。 |
| 关键词: 透解祛瘟颗粒 新型冠状病毒肺炎 网络药理学 分子对接 |
| DOI:10.13506/j.cnki.jpr.2020.12.006 |
| 基金项目: |
|
出版日期:2020-12-25
|
|
| Uncovery of the action mechanisms and major bioactive compounds responsible for the protective effects of Toujie Quwen Granules on COVID-19 based on network pharmacology and molecular docking |
| RAO Hongyu,CHEN Pan,WU Hao,WANG Yonggang,LI Peibo,SU Weiwei |
| (Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-evaluation of Post-marketed TCM, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China) |
| Abstract: |
| Objective To explore the mechanism of action and active constituents of Toujie Quwen Granules (TJQWG) for treatment of COVID-19, and provide a scientific reference for its clinical application.Methods The constituents of TJQWG were collected by using Traditional Chinese Medicine Systems Pharmacology Database (TCMSP). The targets of constituents were collected by using TCMSP and Toxicogenomics Database (CTD). Protein-protein interaction (PPI) data was constructed by using String website for screening key targets.The herb-active constituent-key target network was constructed by using Cytoscape software, followed by topology analysis. The DAVID database was used to perform KEGG pathway analysis on the key targets and molecular docking study was performed to evaluate the interaction between the active constituents and the targets (ACE2, MPro, and PLP), predicting the mechanism of action of TJQWG.Results A total of 132 key targets were screened, such as PTGS2, CASP3, IL6, TNF, TP53, AKT1, MAPK3, VEGFA, MAPK1, STAT3, JUN, GAPDH, INS, ALB, AR and so on. Molecular docking results indicated that a total of 58, 64, and 56 active constituents in TJQWG possess lesser binding energies (below the average) to ACE2, MPro, and PLP, respectively. The results of pathway enrichment indicated that Influenza A, Small cell lung cancer, TNF signaling pathway, Toll-like receptor signaling pathway, PI3K/Akt signaling pathway, and HIF-1 signaling pathway were the key pathways, which were involved in the treatment of COVID-19. Conclusion TJQWG may exhibit therapeutic effects on COVID-19 probably through inhibiting the infection and reproduction of SARS-CoV-2 due to targeting ACE2,MPro and PLP,as well as moderating cytokine release syndrome, hypoxemia, and lung fibrosis based on multi-target and multi-pathway. |
| Key words: Toujie Quwen Granules COVID-19 network pharmacology molecular docking |